Search Results < Yale Cancer Center

263 results

News
Lung Cancer Awareness Q&A with Roy Herbst, MD, PhD
Q&A with Roy Herbst, MD, PhD, medical oncologist, in recognition of Lung Cancer Awareness Month.
15 Nov 2022
News
Meet Yale Internal Medicine: Benjamin Goldman-Israelow, MD, PhD
As part of our “Meet Yale Internal Medicine” series, we are featuring Benjamin Goldman-Israelow, MD, PhD, assistant professor in medicine and former ABIM Physician-Scientist Research Pathway Resident.
7 Nov 2022
News
Will Long COVID Research Provide Answers for Poorly Understood Diseases Like ME/CFS?
ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) is a highly disabling, severe condition that has been largely overlooked and even questioned as an illness by physicians and biomedical researchers for decades. But now, scientists including Yale's Akiko Iwasaki and Harlan Krumholz are finding parallels between post-infection long COVID and ME/CFS.
1 Nov 2022
News
COVID-19 Virus Increases Risk for Other Infections by Disrupting Normal Mix of Gut Bacteria
Infection with the pandemic virus, SARS-CoV-2, can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study finds.
Source: NYU Langone Health
1 Nov 2022
News
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.
Source: YaleNews
27 Oct 2022
News
Liver Cancer Awareness Q&A with David C. Madoff, MD
Q&A with David C. Madoff, MD, Interventional Radiologist, in recognition of Liver Cancer Awareness Month.
25 Oct 2022
News
Scientists researching new scientific approach to identify cancer origins
Previous studies have shown the connection between age, exposure to carcinogens and the risk of developing cancer due to the accumulation of mutations over time. Scientists from Yale University and Emmanuel College demonstrate a new scientific approach to determine the origins of different types of cancer. Jeffrey Townsend, YSPH Elihu Professor of Biostatistics and Ecology & Evolutionary Biology, was a co-author of the study.
Source: The Daily Campus
24 Oct 2022
News
How Jonysah Kept Her Cool, & Kept Her Patients Cared For
Jonysah Bouknight was finishing up giving one patient a “bed bath” when she heard a loud noise — and quickly learned that another patient was having a stroke. She took a deep breath, collected herself, and jumped into action, making sure the patients got the care they needed without letting the stress of her job completely overwhelm her. Bouknight is a patient care associate at Yale New Haven Health’s Smilow Cancer Hospital.
Source: New Haven Independent
21 Oct 2022
News
ADAURA Update: Osimertinib Benefit in Early NSCLC Sustained
An updated analysis of the phase III ADAURA trial revealed a median disease-free survival (DFS) of 5.5 years for early-stage, EGFR-positive non-small cell lung cancer (NSCLC) patients who received osimertinib (Tagrisso) in the postoperative setting, with nearly three in four patients treated with the adjuvant therapy free of disease at 4 years.
Source: MED Page Today
20 Sep 2022
News
The Destructive Power of PROTACs Could Tackle Prostate Cancer
New drug development could help solve the problem of treatment resistance in cancer cells. Yale Urology's Daniel Petrylak, MD, calls it "potent."
Source: Nature
14 Sep 2022
News
Future Directions in the Management of Non–Small Cell Lung Cancer Harboring Driver Mutations
It has been 20 years since the discovery of EGFR mutations and almost 25 years since we first used EGFR inhibitors in the clinic. This resulted in a paradigm shift regarding the way we think about lung cancer. Now that we have drugs which target growth factor receptors, and we use them to slow the growth of tumors, giving rise to dramatic responses.
Source: Cancer Network
14 Sep 2022
News
Biden Hopes Ending Cancer Can Be a 'National Purpose' For US
President Joe Biden is urging Americans to come together for a new “national purpose” — his administration’s effort to end cancer “as we know it.”
Source: ABC News
12 Sep 2022
News
Video: Dr. Petrylak on Enzalutamide Plus Androgen Deprivation Therapy in mHSPC
Daniel P. Petrylak, MD, professor of medicine and urology, coleader, Cancer Signaling Networks, Yale Cancer Center, discusses enzalutamide (Xtandi) plus androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC).
Source: OncLive
11 Sep 2022
News
Dr. Ryan Chow wins 2022 Carolyn Slayman Prize in Genetics
Ryan Chow is the 2022 winner of the Genetics Department’s Carolyn Slayman Prize, which recognizes excellence in scientific research and contribution to the scientific community.
8 Sep 2022
News
Cancer Research Institute To Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated By Ana Patricia Gámez, To Connect The U.S. Hispanic Cancer Community With Information That Can Save Lives
The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system's power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET. This free virtual event, moderated by TV Host and Entrepreneur Ana Patricia Gámez, and presented completely in Spanish, will connect Hispanic cancer patients and caregivers with groundbreaking research updates from leading immunotherapy experts driving scientific breakthroughs and advancements that impact patient care.
Source: PR Newswire
6 Sep 2022
News
Petrylak Provides Insight Into Testing, Multidisciplinary Management in Prostate and Bladder Cancer
Dr. Daniel Petrylak discusses current issues with genetic testing and disease management in prostate and bladder cancer, some of the reasons for poor testing rates, and the importance of proper multidisciplinary management during testing and when seeking to mitigate adverse effects.
Source: OncLive
22 Aug 2022
News
Su Receives Award from Gabrielle's Angel Foundation
Xiaolei Su, PhD, Assistant Professor of cell biology, received an award from the Gabrielle's Angel Foundation for Cancer Research.
17 Aug 2022
News
‘Game-Changing’ Drug Enhertu Now Approved for Certain Types of Lung Cancer — What Does This Mean for Patients?
A targeted therapy called Enhertu, which recently scored a major approval when it comes to treating advanced breast cancer, has now been given the green light by the Food and Drug Administration (FDA) to treat a certain type of lung cancer as well.
Source: Survivornet
16 Aug 2022
News
Rachel Perry to Speak on Metabolism and Cancer
Rachel Perry, PhD, has been invited to speak about her work in the growing field of cancer metabolism.
15 Aug 2022
News
Roy S. Herbst, MD, PhD, Examines the Use of Ramucirumab Plus Pembrolizumab in ICI-Resistant Advanced NSCLC
At ASCO 2022, Roy S. Herbst, MD, PhD, reviews a substudy of the phase 2 Lung-MAP trial which investigates ramucirumab plus pembrolizumab for patients with advanced non–small cell lung cancer who demonstrated resistance to previous immunotherapy.
Source: Cancer Network
12 Aug 2022